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ALLERGIES THEN AND NOW 
Prof Dr Claude Favrot 
 
A quick glance at the past…. 
Atopy was first described 1923 by Coca and Cooke and was defined as a familial type of allergy 
associated with an immediate type of hypersensitivity [1]. The first description of atopy in dogs 
was made in 1939 while the first description of flea allergy dates from 1938 and the first review 
article on allergies in animals from 1941[2, 3]. Human reaginic IgE antibodies were described 
simultaneously in 1967 by Johansson and Ishizaka[4]. The canine counterpart was described in 
1971 by Schwartzmann and Halliwell [5]. At that time, the pathogenesis of atopic dermatitis was 
described as a pure IgE reaction: “The clinical signs are due to the formation of reaginic 
sensitizing IgE antibodies…..that fixes to circulating basophils or tissue mast cells. When the cell 
bound antibody comes in contact with the antigen, it causes degranulation of the cell[6] causing 
the liberation of vasoactive amines such as histamine, serotonin and kinins” [6]. The same author 
estimated the incidence of this condition to 15%, which was higher than the incidence in human 
beings at the same period [6]. The clinical signs were directly caused by the effects of the 
vasoactive amines and were described as edema, erythema and pruritus [6].Chamberlain 
mentioned that the feet, the toes, the eyelids, ear pinnas and canals, groin and perineal area were 
mainly affected and that the course of the disease might be chronic, periodic, persistent or 
sporadic. He also described the possible lichenification of the skin in chronic patients. As well, 
he noticed that the clinical signs were reversible when glucocorticoids were applied but that the 
signs relapsed when treatment is discontinued[6]. Atopic dermatitis was caused by intrinsic 
(heredity, emotional and psychogenic factors, hormonal aberrations and autoimmunity) and 
extrinsic (seasonal and non-seasonal inhalants, ingestants, endoparasites and microbes) factors. 
As far as the environmental allergens were concerned, pollens, house dust, fleas and foods were 
considered to be the most relevant for canine atopic dermatitis [7]. The diagnosis of the condition 
was mainly based on the history of the patients, the clinical examination and laboratory tests. 
Chamberlain considered that the main features were family history, eosinophilia, pruritus, the 
relapsing course of the disease and the improvement with gluco-corticoids drugs [6]. As far as 
laboratory tests were concerned, he recommended skin scrapings, bacterial and fungal cultures, 
blood and urianalyses and skin biopsies. Once the allergy was confirmed and/or resembling 
diseases, especially ectoparasites, ruled out, it was recommended to evaluate the role of the food 
and to perform skin testing. Skin testings were strongly recommended and were mainly carried 
out with mixes (Grasses, trees, weeds, molds, epidermals, feathers, insects and bacteria) while 
only ragweed, flea, cotton, kapok and house dust were tested separately [8]. It is worth 
mentioning, that, in the same article, the authors discussed the drawbacks and advantages of 
prick test, patch test and provocation exposure, the latter, especially for foods. In 1974, the 
recommended treatment of canine atopic dermatitis were glucorticioids, antihistamines (even 
though efficiency was considered matter of debate) an allergen-specific immunotherapy [9, 10]. 
Some other somewhat more surprising recommended drugs were also mentioned such as 
periactin and cromoglycate [10]. It also worth mentioning that, in 1974, the relation between 
food allergy and atopic dermatitis as well as the role of staphylococcal infections, fungal and 
bacterial hypersensitivities were also discussed [11-14]. 
2016: are we yet so far away? 
Since 1974, about 750 PubMed-indexed articles on canine atopic dermatitis have been published. 
We may consequently have the impression that we have accomplished major progresses. But is it 
that true? 
Atopic dermatitis prevalence: 
More than 40 years after the article by Chamberlain mentioned above, we still do not have a 
reliable study on the prevalence of this disease [15]! Many authors still regard an AD prevalence 
of 15% (estimation by Chamberlain) as plausible but nobody was able to prove it yet! 
Environmental factors and AD 
As described above, early articles focused mainly on the role of environmental allergens. As 
well, food and microbes were mainly regarded as sources of allergens.  
One should remember that the so-called “hygiene hypothesis” was first described in 1989 [16]. 
Numerous studies carried out in humans have suggested that other environmental factors such as 
microbes, parasites, endotoxins may play a driving role in the development of human AD. Some 
studies have also been carried out in dogs and shed a new light on this aspect of the AD 
pathogenesis. In particular, some studies support, although weakly, the protective role toward the 
development of canine AD, of the contact with microbes [17-20]. 
Genetics 
We noticed already that familial predisposition was recognized very early in human and dogs 
with AD. A link between heredity and the development of the disease was clearly mentioned by 
Chamberlain in 1974. Numerous studies have now been published and proved the association of 
human atopic dermatitis and some genetic mutations, especially fillagrin [21]. In dogs, breed 
predisposition were clearly established [17]. Several genome-wide linkage and association 
studies have been published but only one gene, Plakophillin 2, was clearly associated with AD in 
German shepherd dogs [22]. It is very likely that the great diversity of canine breeds complicated 
these studies. 
Allergens 
The role of environmental, microbial and food allergens was always suspected. However tests 
were mainly carried out with mixes. More importantly, in 1974, most tests for indoor allergens 
were made on dust extracts and not on mites. It is now clear that the most important allergens in 
house dust are mites, especially Dermatophagoides farinae (DF). Since 2000, DF canine major 
and minor allergens have been described. In human, testing are now often carried out on 
allergens and not anymore on whole extracts of mites. This hurdle is still not cleared in 
veterinary allergology. 
As well, in human allergology, the so-called “component- resolved diagnosis” allows the 
allergist not only to identify the main allergens of each patient but also, in some cases, to 
recognize the primary sensitizer [23, 24]. Veterinary allergists are still far away from this 
approach. 
Pathogenesis 
Our view of the pathogensis of AD is increasingly complex. We do not regard anymore AD as a 
pure IgE reaction. First, a lot of attention has been paid to the role of epidermal barrier [25]. The 
identification of the fillagrin gene mutation as one of the most important genetic factor 
associated with AD in humans has shed some light on a previously ignored important aspect of 
the disease. In fact, numerous children with AD have a primary defective stratum corneum. This 
impaired barrier is known to facilitate the penetration of allergens but also the penetration of 
microbes. In dogs, despite the discovery of plakophillin mutation is atopic German shepherd and 
some studies showing a lack of expression of stratum corneum proteins in allergic individuals, it 
is still unclear whether epidermal barrier dysfunction is a primary or secondary change. Pruritus 
is one of the most constant and earlier signs of AD. Pruritus leads naturally to secondary 
impairment of the epidermal barrier. As well, some of the major DF allergens are enzymes that 
may also destroy the upper layer of the skin epithelium. Last but not least secondary bacterial 
and yeast infections may also contribute to a defective protection of the living epidermis. Some 
additional studies are clearly mandatory to determine if the defective barrier is primary or 
secondary in dogs. It should be kept in mind that both scenarios may coexist in some patients 
while one or the other may be more important in other patients. 
The old view of AD favoured a Th2 type pathogenesis of AD. The Th2 phenotype promote the 
production of allergen-specific IgE, the recruitment of inflammatory cells such as eosinophils 
and the activation of hypersensitivity- associated cells such as mast cells. Nowadays it appears 
however obvious that other phenotypes and cell types also play a major role in the development 
of the disease. The Th1 phenotype, in example, is clearly involved in the more chronic stages of 
AD. As well, some studies have shown that T regulatory cells are also important[26]. Some other 
T cells subclasses such Th22 and Th17 are also involved in human AD even though their role in 
canine AD is less studied. 
In addition, the use of microarray gene expression has enabled the identification of previously 
ignored cytokine and inflammatory factors that are likely to be involved. For example, it has 
been recently shown that one of the earlier activated gene in sensitized dogs is IL31, which is 
known to code for highly pruritogenic cytokine. This shows that pruritus is not only a consequent 
of the atopic disease but also of the triggering factor of a very complex cascade. 
The role of IgE itself is questioned [27]. First, the above mentioned studies suggested that 
allergen-specific IgE may be a consequence of the atopic disease and not the primary cause. In 
this regard, the identification, first in humans than in dogs, of patients with an atopic phenotype 
but no demonstrable allergen-specific IgE, the so-called intrinsic or atopic like disease, may be 
regarded as supportive. One more time, it should be kept in mind that AD is a protean and 
complex disease and that not all AD patients have the same disease course and causes.  
All in all, we are still, especially in veterinary allergy, from a global understanding of this 
condition. We have made some progress but, unfortunately, these progresses did not make the 
picture clearer.  
The role of microbial factors. 
As mentioned earlier, the role of microbes, especially bacteria, in AD was very early recognized. 
The role of malassezia was identified later [28]. Microbes are now considered to play a very 
complex role in the development of the disease. First, they could be protective in some 
circumstances. But when the disease develops they contribute to the worsening of the pruritus 
and the impairment of the epidermal barrier. Last but not least, they are also regarded as potential 
allergens in some patients. It is also important to mention that a lot of attention is now paid to the 
microbiome. New amplification and sequencing techniques allowed to uncover the incredible 
complexity and richness of the skin flora. It has been shown that the microbiome of atopic dogs 
is far less complex that the counterpart in healthy individuals [29]. Further studies are however 
needed to draw conclusions of these findings. 
Clinical signs and diagnosis 
As written above, canine AD was first diagnosed in 1939 and the clinical signs of the condition 
were already very well described in the early fifties. The only important change in the 
description of the condition is the rarer association with signs of hay fever. We now know that 
numerous AD dogs only present with skin changes. 
We have shown above that the diagnosis of AS was based on the exclusion of resembling 
diseases such as ectoparasites and on the presence of specific features such as relapsing course, 
pruritus or response to glucocorticoids. In this regard, the only major changes was the 
introduction, first in humans, then in animals of diagnostic criteria. It should however be kept in 
mind that the best validated sets are associated with sensitivity and specificity around 80% and 
that these criteria cannot be regarded as very accurate [30]. In fact, they are mainly used in the 
context of clinical studies to ensure recruitment homogeneity. These sets of criteria have also 
been developed in specialized practices and have not been validated for the use in general 
practices [31]. 
Treatment and management 
Glucocorticoids, antihistamines and allergen-specific immunotherapy were the recommended 
tools in 1974. During these four decades numerous drugs were tested, advocated, promoted but 
glucorticoids and ASIT are still widely used. ASIT is still considered as the sole etiologic 
treatment of AD. Recently some new routes for ASIT such as ILIT and SLIT (intralymphatic and 
sub-lingual, respectively) have been described and seem promising. As well some protocol for 
rush immunotherapy have been described. But as mentioned above, the next step, in veterinary 
allergology, should be the use of allergen-based-ASIT. 
Only two drugs have really changed the management of canine AD in the last forty years: 
Cyclopsorine A and Oclacitinib [32-34]. The former has the big advantage to be used on the 
long-term with limited side-effects and to be tapered relatively quickly. The latter controls 
pruritus very quickly and does not seems to induce severe side-effects. 
It could be anticipated that other drugs will soon be available. This is mainly because atopic 
diseases in humans (atopic dermatitis but also hay fever, food allergy and asthma) are considered 
to be one of the most prevalent conditions and that a lot of research on these disease is currently 
made. As the dog is considered as the best natural model for this human conditions, it will profit 
from this extensive research. 
In this regard, the use of anti-cytokine or anti-immunoglobulins antibodies are extremely 
promising. 
What else? 
As mentioned several times before, AD is a protean, multifaceted disease and we have now 
understood that a more global, and holistic approach of the management is needed. In this regard, 
the role of food, epidermal barrier treatments, anti-bacterial peptides should be more extensively 
investigated and will probably be implemented in the near future for a better management of 
atopic patients. 
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